Dr. Ilene Harris Was Recently Published In Five Prominent Health Publications

Thursday, August 20, 2015

Dr. Ilene Harris

Dr. Ilene Harris (previously Zuckerman), a Managing Director and Principal Research Scientist in IMPAQ’s Health Division, recently co-authored several articles published in five prominent health publications, listed below.

Dr. Harris has more than 30 years of experience in geriatrics, medication use and quality, medication adherence, long-term care, dementia, traumatic brain injury, and drug policy and program evaluation. Her research focuses on assessment of quality and appropriateness of care in long term care and community settings, care transitions into and out of nursing homes, and development of medication quality measures.

Albrecht J.S., Khokhar B., Pradel F., Campbell M., Palmer J., Harris I. & Palumbo F. (2015). Perceptions of patient provider agreements. Journal of Pharmaceutical Health Services Research, 6(3):139-144. doi: 10.1111/jphs.12099.

Stolker J.M., Badawi O., Spertus J.A., Nasir A., Kennedy K.F., Harris I., Franey C.S., Doren Hsu V., Ripple G.R., Howell G.H., Lem V.M., Chan P.S. (2015). Intensive care units with low versus high volume of acute myocardial infarction: clinical outcomes, resource utilization, and quality metrics. Journal of American Heart Association, 4(6): e001225. doi: 10.1161/JAHA.114.001225.

Shen X., Zuckerman I.H., Palmer J.B., Stuart B. (2015). Trends in prevalence for moderate-to-severe pain and persistent pain among Medicare beneficiaries in nursing homes, 2006-2009. Journal of Gerontology, Series A Biological Sciences, Medical Sciences. 70(5):598-603.

Li M, Harris I, Lu KZ. (2015). Differences in proxy-reported and patient-reported outcomes: assessing health and functional status among Medicare beneficiaries. BMC Medical Research Methodology. 15:62. DOI 10.1186/s12874-015-0053-7.

Albrecht J.S., Liu X., Baumgarten M., Langenberg P., Rattinger G.B., Smith G.S., Gambert S.R., Gottlieb S.S., Zuckerman I.H. (2014). Benefits and risks of anticoagulation resumption following traumatic brain injury. JAMA Internal Medicine. 174(8):1244-51. doi: 10.1001/jamainternmed.2014.2534. PMID: 24915005. Comment in Albrecht J.S., Liu X., Zuckerman I.H. (May, 2015). Risks and benefits of resumption of anticoagulation following traumatic brain injury remain complex and uncertain-reply. JAMA Internal Medicine. 175(5):866. PMID: 25938318.